iBio, Inc.
IBIO· Nasdaq
IBIOiBio, Inc.
Filed Sep 30, 2013 · 10-K · 92 days after period end · 0001144204-13-053105
derived · Computed from the longer spans the company filed.
| Metric | Q4 2013dderived from reported figures | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures |
|---|---|---|---|
| Revenue | $617.00K | $351.07K | — |
| Net Income | -$1.32M | -$1.36M | -$1.58M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
iBio, Inc. · CIK 1420720 · Engraved from SEC EDGAR
ended Jun 30, 2013 · filed Sep 30, 2013 · 92 d after period end
